THE INTERPLAY BETWEEN ANTI-CD20 THERAPEUTIC ANTIBODIES AND "MEMORY" NATURAL KILLER CELLS

被引:0
|
作者
Capuano, Cristina [1 ]
Battella, Simone [2 ]
Pighi, Chiara [2 ]
Franchitti, Lavinia [2 ]
Santoni, Angela [2 ]
Galandrini, Ricciarda [1 ]
Palmieri, Gabriella [1 ]
机构
[1] Sapienza Univ, Dept Expt Med, Rome, Italy
[2] Sapienza Univ, Dept Mol Med, Lab Pasteur Italia Fdn Cenci Bolognetti, Rome, Italy
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
562
引用
收藏
页码:21 / 22
页数:2
相关论文
共 50 条
  • [31] The therapeutic potential of anti-CD20 - What do B-cells do?
    Eisenberg, R
    Looney, RJ
    [J]. CLINICAL IMMUNOLOGY, 2005, 117 (03) : 207 - 213
  • [32] Role of neutrophils in the activity of therapeutic anti-CD20 MAbs
    Golay, J.
    Da Roit, F.
    Bologna, L.
    Ferrara, C.
    Leusen, J.
    Rambaldi, A.
    Klein, C.
    Introna, M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 : 18 - 19
  • [33] Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies
    Introna, M
    Barbui, AM
    Bambacioni, F
    Casati, C
    Gaipa, G
    Borleri, G
    Bernasconi, S
    Barbui, T
    Golay, J
    Biondi, A
    Rambaldi, A
    [J]. HUMAN GENE THERAPY, 2000, 11 (04) : 611 - 620
  • [34] Bispecific Anti-CD20/Anti-CD22 Antibodies with Potent Lymphoma Cytotoxicity
    Rossi, Edmund A.
    Chang, Chien-Hsing
    Cardillo, Thomas M.
    Stein, Rhona
    Pilas, Diana
    Nordstrom, Diane L.
    Kopinski, John
    Goldenberg, David M.
    [J]. BLOOD, 2008, 112 (11) : 564 - 565
  • [35] Therapeutic effects of the anti-CD74 mAb, milatuzumab, compared to anti-CD20 antibodies, in B-cell lymphomas
    Stein, Rhona
    Goldenberg, David M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3353S - 3354S
  • [36] Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
    Skarzynski, Martin
    Niemann, Carsten U.
    Lee, Yuh Shan
    Martyr, Sabrina
    Maric, Irina
    Salem, Dalia
    Stetler-Stevenson, Maryalice
    Marti, Gerald E.
    Calvo, Katherine R.
    Yuan, Constance
    Valdez, Janet
    Soto, Susan
    Farooqui, Mohammed Z. H.
    Herman, Sarah E. M.
    Wiestner, Adrian
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (01) : 86 - 95
  • [37] Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells
    Small, George W.
    McLeod, Howard L.
    Richards, Kristy L.
    [J]. PEERJ, 2013, 1
  • [38] The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenstrom macroglobulinemia
    Le Garff-Tavernier, Magali
    Herbi, Linda
    de Romeuf, Christophe
    Azar, Nabih
    Roos-Weil, Damien
    Bonnemye, Patrick
    Urbain, Remi
    Leblond, Veronique
    Merle-Beral, Helene
    Vieillard, Vincent
    [J]. HAEMATOLOGICA, 2015, 100 (04) : E147 - E151
  • [39] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [40] Parameters critical for the effector mechanism of anti-CD20 antibodies revisited
    Stasilojc, Grzegorz
    Felberg, Anna
    Okroj, Marcin
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (06) : 777 - 779